Genetics of Longevity: How Genes Influence Lifespan

1. Human Longevity Has a Genetic Component Human lifespan is influenced by both genetic and non-genetic factors. Family and twin studies show that longevity has a heritable component, although genetics explains only part of the differences between individuals. This genetic influence may become more important at the extremes of lifespan, making exceptionally long-lived individuals and their families valuable models for studying healthy longevity.

2. There Is No Single “Longevity Gene” Many genetic variants have been associated with longevity, but relatively few findings have been consistently replicated across populations. Human longevity is therefore best understood as a complex genetic trait, shaped by many variants with relatively small effects interacting with one another and with environmental factors.

3. APOE Is the Most Consistently Replicated Longevity Locus Among genetic variants associated with human longevity, APOE has shown the strongest and most consistent evidence across different populations. The APOE gene has three common alleles: ε2, ε3 and ε4. We inherit one allele from each parent, creating genotypes such as ε3/ε3, ε3/ε4 or ε4/ε4. ε3/ε3 is the most common genotype and is generally used as the reference. ε3/ε4 means that a person carries one copy of the ε4 allele, while ε4/ε4 means carrying two copies. In longevity studies, the ε4 allele is less frequent among exceptionally long-lived individuals, while the ε2 allele is more frequent. APOE is also involved in cholesterol metabolism, one of the biological processes highlighted by the review as consistently linked to longevity. Importantly, APOE should not be interpreted as a simple “positive” or “negative” genetic result. It represents genetic predisposition rather than a diagnosis or prediction of lifespan. APOE therefore illustrates an important principle: genetic variants may influence longevity partly by changing susceptibility to diseases that affect survival into older age.

4. FOXO3 Is One of the Most Consistently Replicated Genes Associated With Longevity FOXO3 is one of the few genes repeatedly associated with exceptional human longevity across different populations. FOXO3 is involved in insulin/IGF-1 signaling and helps regulate cellular responses to stress and metabolism. Functional studies of several longevity-associated FOXO3 variants suggest that they can influence FOXO3 expression, particularly under stressful conditions. Several genetic variants within the FOXO3 region have been associated with a greater likelihood of reaching exceptional old age. However, FOXO3 should not be interpreted as a simple “longevity gene.” Unlike APOE, which is commonly reported as combinations such as ε3/ε3 or ε3/ε4, FOXO3 longevity research involves several different genetic variants, and their associations can differ between populations. Having a longevity-associated FOXO3 variant therefore does not mean that an individual is genetically programmed to live longer. Instead, FOXO3 provides evidence that biological processes involved in cellular stress response, metabolism and resilience may contribute to healthy longevity.

5. Five Biological Processes Show the Strongest Links With Longevity By combining evidence from humans, model organisms and comparative genomics, the authors identified five major biological processes-or pathways-most consistently linked to longevity: Insulin/IGF-1 signaling - nutrient sensing, metabolism and responses to cellular stress. DNA damage response and repair - maintenance of genomic integrity. Immune function - regulation of infection, inflammation and immune balance. Cholesterol metabolism - lipid regulation and cardiovascular health. Telomere maintenance - chromosome stability and cellular replicative capacity. The convergence of different research approaches on these biological processes suggests that they represent important mechanisms involved in healthy longevity.

6. Common Genetic Variants Explain Only a Small Part of Longevity Despite the growing number of genetic studies, only a small number of genetic loci-most notably APOE and FOXO3-have been consistently associated with human longevity across different populations. This suggests that exceptional longevity is unlikely to be explained by a small number of common genetic variants with large effects. Instead, the inherited component of longevity appears to be considerably more complex, with many genetic influences likely contributing to differences in survival and healthy aging.

7. Rare Genetic Variants May Hold Important Clues The authors highlight rare genetic variants as an important direction for future longevity research, particularly variants affecting biological processes already linked to aging and longevity. Because rare variants are difficult to detect in conventional population studies, identifying them will need to be combined with functional research to determine whether they actually influence longevity-related biology. Studying exceptionally long-lived individuals may be particularly valuable for identifying rare genetic characteristics that contribute to healthy survival into advanced age.

8. Genetics Alone Cannot Explain Longevity Even a favorable genetic profile does not guarantee exceptional longevity. Genetic influences interact throughout life with environment, lifestyle, disease risk and other biological factors. Human longevity therefore reflects a complex combination of inherited biology and influences accumulated across the lifespan. Genetics can help explain part of why individuals differ in their susceptibility to age-related disease and exceptional longevity, but it cannot determine an individual lifespan.

The genetics of longevity has moved beyond the idea that exceptionally long life might be explained by discovering a small number of powerful “longevity genes.” Instead, research increasingly points toward a complex combination of genetic variants influencing biological processes involved in aging, resilience and susceptibility to disease.

This is important because several of the processes highlighted by genetic research-nutrient sensing, DNA repair, immune regulation, lipid metabolism and telomere maintenance-are also central to modern aging biology. Genetic studies therefore provide another way of identifying mechanisms that may contribute to healthy survival.

The findings may also help explain why longevity varies so widely between individuals. Some people may inherit combinations of genetic variants that reduce vulnerability to particular age-related diseases or support biological maintenance and resilience for longer.

But genes are only part of the picture. Even among individuals with favorable genetic characteristics, lifespan and healthspan remain influenced by environmental exposures, lifestyle, medical care, disease and other factors accumulated throughout life.

The broader message for longevity medicine is therefore not that lifespan is predetermined by our DNA.

Rather, genetics can help reveal biological processes that influence how we age and why some individuals may be more resilient to age-related disease than others.

Understanding these biological processes may ultimately help identify mechanisms that could become relevant to future prevention or treatment strategies.

For clinicians, the key question is which longevity-associated genetic findings can actually be measured and whether they provide clinically useful information.

Variants involving APOE and FOXO3 can be identified through genetic testing, while broader genetic variation can be assessed using genome-wide genotyping or sequencing. However, these results cannot reliably predict how long an individual will live.

Some aspects of the biological processes associated with longevity can also be assessed through established clinical measures. Cholesterol and lipid metabolism can be evaluated with a lipid profile, while metabolic health and insulin-related processes can be assessed using glucose, HbA1c and other metabolic markers. Selected blood biomarkers can provide information about immune and inflammatory status.

Importantly, these measurements provide different types of information.

Genetic testing identifies inherited predisposition, while clinical biomarkers reflect the patient’s current biological and metabolic state. Both should be interpreted in the context of family history, lifestyle and established disease risk.

Other mechanisms highlighted in longevity research, including DNA repair capacity and telomere maintenance, remain primarily research measures and are not established standalone tools for routine longevity assessment.

For current clinical practice, genetic information should therefore complement-not replace-validated clinical assessment, including cardiovascular and metabolic risk, family history, physical and cognitive function, and lifestyle.

As genetic datasets improve and rare variants become better understood, genetics may increasingly support personalized prevention and individual risk assessment. Its clinical value, however, will depend on demonstrating that genetic information improves risk assessment and leads to meaningful improvements in health outcomes.

Genetic information can help identify inherited risks and relevant biological processes-but it cannot tell us how long an individual person will live.